Extracellular vesicles are tiny bubble-like structures secreted by multiple cell types including astrocytes, microglia and muscle. A number of studies suggest that vesicles may have a key role in the spread of elements that are toxic to neurons and other cell types. These neurotoxic contents may include various biomolecules, such as misfolded proteins or toxic aggregates.
The neuromuscular team at Ulster has studied the role of vesicles in Amyotrophic lateral sclerosis (ALS). ALS is a devastating condition with an average age of onset at 55-70 years old, and a life expectancy of 2-5 years from the time of diagnosis. Diagnosis itself is difficult and time consuming, requiring numerous clinical assessments and taking up to 15 months to confirm. Current treatments are only minimally effective.
The neuromuscular team has found that the release of vesicles is abnormal in the muscles of ALS patients: vesicles from ALS patient muscle cells are toxic to motor neuron cells in the lab. Since these vesicles enter the bloodstream, they could have a key role in cell-cell communication. Muscle vesicles may prove useful as biomarkers and drug targets for a range of health conditions. Cross-talk between muscle and different types of cells is understudied, has general relevance to many hallmarks of both ageing and neuromuscular disorders, and may have important roles beyond.
The current project will use murine models to further explore the role in cell-cell communication of vesicles in ALS and in other neuromuscular and neurodegenerative disorders.
This PhD would be suitable for candidates with a background in a health or life sciences discipline or related subject (e.g. Personalised Medicine, Molecular & Cellular Biology, Medicine, Genetics, Biology, Biomedical Science, Pharmacy/Pharmaceutical Science, Biochemistry)
Key skills required:
Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the proposed area of study.
We may also consider applications from those who hold equivalent qualifications, for example, a Lower Second Class Honours Degree plus a Master’s Degree with Distinction.
In exceptional circumstances, the University may consider a portfolio of evidence from applicants who have appropriate professional experience which is equivalent to the learning outcomes of an Honours degree in lieu of academic qualifications.
If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.
The University is an equal opportunities employer and welcomes applicants from all sections of the community, particularly from those with disabilities.
Appointment will be made on merit.
The University offers the following levels of support:
The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £19,237 (tbc) per annum for three years (subject to satisfactory academic performance).
This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.
Due consideration should be given to financing your studies. Further information on cost of living
Anakor E, et al. The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes. Cells. 2022 Mar 1;11(5):845. doi: 10.3390/cells11050845. PMID: 35269468; PMCID: PMC8909615 (2022).
Le Gall L, et al. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. J Cachexia Sarcopenia Muscle. 2022 Feb 22. doi: 10.1002/jcsm.12945. PMID: 35194965 (2022).
Le Gall, L. et al. Molecular and Cellular Mechanisms Affected in ALS. J. Pers. Med. 10, 101 (2020).
Chiò, A. & Traynor, B. J. Motor neuron disease in 2014. Biomarkers for ALS--in search of the Promised Land. Nat. Rev. Neurol. 11, 72–4 (2015).
Vijayakumar, U. G. et al. A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Front. Neurol. 10, (2019).
Sawada, H. Considerations for pharmacotherapy use in patients with amyotrophic lateral sclerosis: the earlier it starts, the better the results. Expert Opin. Pharmacother. 20, 1671–1674 (2019).
Le Gall, L. et al. Optimized method for extraction of exosomes from human primary muscle cells. Skelet. Muscle 10, 20 (2020).
Submission deadline
Friday 10 May 2024
04:00PM
Interview Date
Week Commencing 27 May 2024
Preferred student start date
16 September 2024
Telephone
Contact by phone
Email
Contact by email